Literature DB >> 18598089

Triazole-modified histone deacetylase inhibitors as a rapid route to drug discovery.

Tracey Pirali1, Francesca Pagliai, Ciro Mercurio, Roberto Boggio, Pier Luigi Canonico, Giovanni Sorba, Gian Cesare Tron, Armando A Genazzani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18598089     DOI： 10.1021/cc800061c

Source DB:  PubMed          Journal:  J Comb Chem        ISSN： 1520-4766


× No keyword cloud information.
  6 in total

1.  3'-(1,2,3-Triazol-1-yl)-3'-deoxythymidine analogs as substrates for human and Ureaplasma parvum thymidine kinase for structure-activity investigations.

Authors:  Jay Lin; Vincent Roy; Liya Wang; Li You; Luigi A Agrofoglio; Dominique Deville-Bonne; Tamara R McBrayer; Steven J Coats; Raymond F Schinazi; Staffan Eriksson
Journal:  Bioorg Med Chem       Date:  2010-03-15       Impact factor: 3.641

2.  Expedient Synthesis of SMAMPs via Click Chemistry.

Authors:  Tsung-Hao Fu; Yan Li; Hitesh D Thaker; Richard W Scott; Gregory N Tew
Journal:  ACS Med Chem Lett       Date:  2013-07-22       Impact factor: 4.345

3.  In silico modification of suberoylanilide hydroxamic acid (SAHA) as potential inhibitor for class II histone deacetylase (HDAC).

Authors:  Usman S F Tambunan; N Bramantya; Arli A Parikesit
Journal:  BMC Bioinformatics       Date:  2011-11-30       Impact factor: 3.169

4.  Store-Operated Calcium Entry as a Therapeutic Target in Acute Pancreatitis: Discovery and Development of Drug-Like SOCE Inhibitors.

Authors:  Marta Serafini; Celia Cordero-Sanchez; Rosanna Di Paola; Irene P Bhela; Silvio Aprile; Beatrice Purghè; Roberta Fusco; Salvatore Cuzzocrea; Armando A Genazzani; Beatrice Riva; Tracey Pirali
Journal:  J Med Chem       Date:  2020-11-30       Impact factor: 7.446

5.  Molecular dynamics simulation of complex Histones Deacetylase (HDAC) Class II Homo Sapiens with suberoylanilide hydroxamic acid (SAHA) and its derivatives as inhibitors of cervical cancer.

Authors:  Usman Sumo Friend Tambunan; Ridla Bakri; Tirtana Prasetia; Arli Aditya Parikesit; Djati Kerami
Journal:  Bioinformation       Date:  2013-07-17

6.  Exploring novel capping framework: high substituent pyridine-hydroxamic acid derivatives as potential antiproliferative agents.

Authors:  Fernando Hernández-Borja; Itzel Mercado-Sánchez; Yolanda Alcaraz; Marco A García-Revilla; Clarisa Villegas Gómez; David Ordaz-Rosado; Nancy Santos-Martínez; Rocío García-Becerra; Miguel A Vazquez
Journal:  Daru       Date:  2021-07-23       Impact factor: 4.088
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.